schemaVersion:

Form C: Filer Information

Filer CIK:
0002020332 
Filer CCC:
XXXXXXXX 
Period:

12-31-2025 

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

32 Biosciences, Inc. 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

DELAWARE  

Date of Incorporation/Organization:

06-05-2023 

Physical Address of Issuer:

Address 1:

3333 GREEN BAY RD 

Address 2:

SUITE 210 

City:

ILLINOIS 

State/Country:

ILLINOIS  

Mailing Zip/Postal Code:

60064 

Website of Issuer:

https://32biosciences.com/ 

Is there a Co-issuer? Radio button not checked Yes Radio button checked No

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

7.00 

Total Assets Most Recent Fiscal Year-end:

2091486.00 

Total Assets Prior Fiscal Year-end:

1478698.00 

Cash and Cash Equivalents Most Recent Fiscal Year-end:

1857311.00 

Cash and Cash Equivalents Prior Fiscal Year-end:

1183699.00 

Accounts Receivable Most Recent Fiscal Year-end:

0.00 

Accounts Receivable Prior Fiscal Year-end:

0.00 

Short-term Debt Most Recent Fiscal Year-end:

358681.00 

Short-term Debt Prior Fiscal Year-end:

14917.00 

Long-term Debt Most Recent Fiscal Year-end:

5378215.00 

Long-term Debt Prior Fiscal Year-end:

3177281.00 

Revenue/Sales Most Recent Fiscal Year-end:

0.00 

Revenue/Sales Prior Fiscal Year-end:

53691.00 

Cost of Goods Sold Most Recent Fiscal Year-end:

0.00 

Cost of Goods Sold Prior Fiscal Year-end:

0.00 

Taxes Paid Most Recent Fiscal Year-end:

0.00 

Taxes Paid Prior Fiscal Year-end:

0.00 

Net Income Most Recent Fiscal Year-end:

-3091429.00 

Net Income Prior Fiscal Year-end:

-1742797.00 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

32 Biosciences, Inc. 

Signature:

Peter Farmakis 

Title:

Chief Executive Officer 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Peter Farmakis 

Title:

Chairman 

Date:

04-24-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Jayson Slotnik  

Title:

Director 

Date:

04-24-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Franklin R. Cockerill III 

Title:

Director 

Date:

04-24-2026